$Iovance Biotherapeutics(IOVA.US)$Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer 4 MINUTES AGO, 6:30 AM EST VIA GLOBENEWSWIRE
$Iovance Biotherapeutics(IOVA.US)$ 02/20/2024 - 06:30 AM SAN CARLOS, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced the pricing of an underwritten offering of 23,014,000 shares of its common stock at an offering price of $9.15 per sh...
$Iovance Biotherapeutics(IOVA.US)$Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock 2 MINUTES AGO, 6:30 AM EST VIA GLOBENEWSWIRE
$Iovance Biotherapeutics (IOVA.US)$ by looking at the daily I thought there would be more pull back on Tuesday, but questioning that with the after hours movement
JESSE JAMES8832 : 在
Trytosaveabit樓主 JESSE JAMES8832: 不錯!GL
Trytosaveabit樓主 JESSE JAMES8832: 真的!